BlossomHill Therapeutics, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
31.8M
on 2026-09-16, from 2.55M on 2026-06-30 10-Q ↗
a raise that quarter, at its price
Newest
None
No S-3 or F-3 shelf on file in the last 30 months.
None
No at-the-market programme on file in the last 30 months.
Warrants
No warrant count read from a 10-Q or 10-K.
Cash
Four quarters of operating cash flow to 2026-06-30 are not all on file.
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-08-07 | Public offering | 9,375,000 | $16.00 | not read | 424B4 ↗ |